Ask The Pharmacist: Topical vs. Systemic Pain Medication
April 1, 2024
3 MIN READManaging chronic pain with medications can be difficult for various reasons. Pain experiences and treatment effectiveness may differ among individuals and caregivers.
Enlyte Quarterly Medical Price Index
March 19, 2024
3 MIN READAs reported by the Bureau of Labor and Statistics (BLS) in February 2024, the consumer price index in the United States increased 3.1% over the preceding 12 months. The medical care index rose 0.5% in January 2024. The index for hospital services increased 1.6% over the month and the index for physician’s services increased 0.6% which would be compared to Enlyte’s data in this report.
Ask The Pharmacist: The Role of a Pharmacy and Therapeutics (P&T) Committee
March 1, 2024
2 MIN READA Pharmacy and Therapeutics (P&T) committee plays a crucial role in the realm of health care, particularly in the context of a workers’ compensation pharmacy benefit manager (PBM). This committee is comprised of health care professionals, such as physicians and pharmacists, who are responsible for evaluating and making decisions about the formulary—a continually updated list of medications covered by a prescription drug plan.
Closing Loopholes: Tackling Drug Price Inflation in Work Comp
February 22, 2024
Enlytened Trends Report 2024 Annual Edition
February 7, 2024
22 MIN READBe the first to know how emerging trends in generative AI, auto and casualty claims and regulatory compliance are impacting P&C this year and beyond.
Ask The Pharmacist: Risk Assessment for Opioid Use Disorder (OUD)
February 6, 2024
3 MIN READOn December 19, 2023, the U.S. Food and Drug Administration (FDA) approved the first test (AvertD) that uses DNA in assessing whether certain individuals may have an elevated risk of developing opioid use disorder (OUD).
Ask The Pharmacist: Fixed-Dose Combination Drugs in Workers’ Comp
January 10, 2024
3 MIN READFixed-dose combination drug products (FDCDPs) are made up of two different drug ingredients in a single formulation, containing a fixed amount of each. Among the more recognizable examples of these are Symbicort (budesonide-formoterol), Suboxone (buprenorphine-naloxone), Treximet (sumatriptan-naproxen), and Tylenol PM (acetaminophen-diphenhydramine). Several FDCDPs for pain management also exist such as Vimovo (naproxen-esomeprazole), Duexis (ibuprofen-famotidine), and Seglentis (celecoxib-tramadol).